Texas Oncology Cancer Center   Report issue

Academic/Hospital Phase 2
Founded: TX United States (1986)

Organization Overview

First Clinical Trial
2008
NCT00700011
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now